Related Experiment Video
Updated: Dec 30, 2025
11:13
Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 3. Aerobiology
Published on: October 3, 2016
15.0K
Proposed Changes to U.S. Policy on Potential Pandemic Pathogen Oversight and Implementation
Thomas V Inglesby1, Marc Lipsitch2
1Center for Health Security, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA tinglesby@jhu.edu.
Msphere
|January 24, 2020
Summary
This study proposes policy changes for potential pandemic pathogen (PPP) oversight, advocating for transparency, responsible publication, and international collaboration in enhanced PPP research to improve biosafety and biosecurity globally.
Area of Science:
- Public Health Policy
- Biosafety and Biosecurity
- Infectious Disease Research
Background:
- Current U.S. government policies for potential pandemic pathogen (PPP) oversight require updates.
- Enhanced PPP research necessitates robust biosafety and biosecurity measures.
- A fragmented international approach to enhanced PPP research poses risks.
Purpose of the Study:
- To propose revisions to U.S. government policy on PPP oversight.
- To advocate for enhanced transparency in the review and publication of PPP research.
- To promote a unified international strategy for managing enhanced PPP research.
Main Methods:
- Policy analysis and proposal development.
- Emphasis on transparency in review processes and research content.
- Advocacy for best practices in biosafety and biosecurity.
Main Results:
- Recommendations for increased transparency in PPP review and publication.
- Proposal for high-level approval of enhanced PPP experiments.
- Call for international harmonization of PPP research standards.
Conclusions:
- Implementing transparent policies and best practices is crucial for responsible enhanced PPP research.
- International cooperation is essential for global biosafety and biosecurity in PPP research.
- Adoption of these recommendations by funders and journals will strengthen oversight.
Related Concept Videos
01:18Steps in Outbreak Investigation
435
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
435
01:26Principles of Disease Surveillance
416
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
416
01:03Drug Control Governance: Regulatory Bodies and Their Impact
430
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
430
01:25Drug Regulation
2.6K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.6K
01:26FDA Approved Drugs: Changes to Approved Drugs
155
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
155
01:19Pharmacovigilance
1.5K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.5K